Effects of inhibitory activity on mycelial growth of candida albicans and therapy for murine oral candidiasis by the combined use of terpinen-4-ol and a middle-chain fatty acid, capric acid

Yakugaku Zasshi

Volumn 133, Issue 1, 2013, Pages 133-140

  Ninomiya, Kentaro ^a   Hayama, Kazumi ^a   Ishijima, Sanae ^a   Takahashi, Miki ^a   Kurihara, Junichi ^a   Abe, Shigeru ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Candida albicans; Capric acid; Essential oil; Terpinen 4 ol

Indexed keywords

DECANOIC ACID; TERPINEN 4 OL;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; MURINAE; MYCELIAL GROWTH; NONHUMAN; THRUSH;

EID: 84922686586     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.12-00242     Document Type: Article

References (23)

1. Odds F. C., "Candida and Candidosis: A Review and Bibliography, " Bailliere Tindale, London, 1988, pp. 1-152.
2. Meitner S. W., Bowen W. H., Haidaris C. G., Infect. Immun., 58, 2228-2236 (1990).
3. Ninomiya K., Maruyama N., Inoue S., Ishibashi H., Takizawa T., Oshima H., Abe S., Biol. Pharm. Bull., 35, 861-865 (2012).
4. Mondello F., De Bernardis F., Girolamo A., Cassone A., Salvatore G., BMC Infect. Dis., 6, 158 (2006).
5. Takahashi M., Inoue S., Hayama K., Ninomiya K., Abe S., Med. Mycol. J., 53, 255-261 (2012).
6. Ishijima S. A., Hayama K., Burton J. P., Reid G., Okada M., Matsushita Y., Abe S., Appl. Environ. Microbiol., 78, 2190-2199 (2012).
7. Maruyama N., Takizawa T., Ishibashi H., Hisajima T., Inouye S., Yamaguchi H., Abe S., Biol. Pharm. Bull., 31, 1501-1506 (2008).
8. Maebashi K., Niimi M., Kudoh M., Fischer F. J., Makimura K., Niimi K., Piper R. J., Uchida K., Arisawa M., Cannon R. D., Yamaguchi H., J. Antimicrob. Chemother., 47, 527-536 (2001).
9. Abe S., Satoh T., Tokuda Y., Tansho S., Yamaguchi H., Mycrobiol. Immunol., 38, 385-388 (1994).
10. Wakabayashi H., Abe S., Teraguchi S., Hayasawa H., Yamaguchi H., Antimicrob. Agents Chemother., 42, 1587-1591 (1998).
11. "Antibiotics in Laboratory Medicine, " 3rd ed., ed. by Lorian V., Williams & Wilkins, Baltimore, 1991.
12. National Committee for Clinical Laboratory Standards (NCCLS), "Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Proposed Standard, " Document M27-P, NCCLS, Villanova, 1992.
13. Takakura N., Sato Y., Ishibashi H., Oshima H., Uchida K., Yamaguchi H., Abe S., Microbiol. Immunol., 47, 321-326 (2003).
14. D'Auria F. D., Laino L., Strippoli V., Tecca M., Salvatore G., Battinelli L., Mazzanti G., J. Chemother., 13, 377-383 (2001).
15. Hammer K. A., Carson C. F., Riley T. V., Med. Mycol., 38, 355-362 (2000).
16. Hammer K. A., Carson C. F., Riley T. V., J. Appl. Microbiol., 95, 853-860 (2003).
17. Murzyn A., Krasowska A., Stefanowicz P., Dziadkowiec D., Łukaszewicz M., PLoS One, 5, e12050 (2010).
18. Bergsson G., Arnfinnsson J., Steingrímsson O., Thormar H., Antimicrob. Agents Chemother., 49, 3209-3212 (2001).
19. Hall R. A., Turner K. J., Chaloupka J., Cottier F., De Sordi L., Sanglard D., Levin L. R., Buck J., Muählschlegel F. A., Eukaryot. Cell, 10, 1034-1042 (2011).
20. Inoue S., Abe S., "An Invitation to Anti-infectious Aromatherapy, " Fragrance Journal LTD., Tokyo, 2011.
21. Brand C., Ferrante A., Prager R. H., Riley T. V., Carson C. F., Finlay-Jones J. J., Hart P. H., Inflamm. Res., 50, 213-219 (2001).
22. Taguchi Y., Hayama K., Okada M., Sagawa T., Arai R., Abe S., Med. Mycol. J., 52, 145-152 (2011).
23. Hart P. H., Brand C., Carson C. F., Riley T. V., Prager R. H., Finlay-Jones J. J., Inflamm. Res., 49, 619-626 (2000).